BGI: The Future of Genetic Research — Shenzhen 100 Fast Riser
BGI is a biotechnology and biogenetic company that specializes in genetic research, sequencing, and modification. To thrive in the medical industry, they rely on scientific research and development.
BGI hope that through continued medical research and studies into the life science industry they can benefit mankind as a whole, allowing everyone to enjoy the implications of their success.
The world’s biggest genomics organization
On November 6th, the 11th International Conference on Genomics was hosted at China’s National Genepark in Shenzhen. BGI united distinguished scientists from all over the world to discuss life science and technology exploration as well as the launch of the BGI’s Gene Sequencer BGISEQ-50.
Wang Jian founded BGI in 1999 and represented China when he attended the International Human Genome Project. Under his leadership, BGI’s team of experts completed the first Chinese gene map in 2007. During 2010, BGI spent a large sum of money building the largest genome platform in the world and the first National Gene Bank, operated by BGI, was officially launched in September this year.
Genetic decoding is based on big data
Gene sequencing can provide answers for many of life’s unfortunate genetic issues and can also help us repair the innate pathogenic genes of our future. BGI, a leader in their industry, has created cutting-edge gene sequencing technology that can reduce costs of gene sequencing so that everyone can benefit from its attributes.
“Genetic decoding is based on big data analysis. The human genome contains 25,000 genes, scientists who want to break each gene for multigene disease and gene mutation need to accumulate big data.” Yanmei Zhu said. BGI is constantly accumulating large sample sizes for their scientific discoveries because they understand that big data brings great value and market changes.
Shenzhen 100 Fast Risers
BGI is a global organization with more than 3,000 global partners. Its business operations cover approximately 66 countries and regions, employing more than 5,000 scientific researchers over these areas. With the disruptive gene technology and globalization strategies, BGI was selected as one of Shenzhen’s Top 10 Fast Risers in CSOFT’s Shenzhen 100 Report. BGI, through the industrial-academic-research, greatly promoted development with global branches and established cooperation within the industrial chain.
The most amazing thing about gene sequencing is that we can have the ability to reconstruct the past and foresee the future.
Initially this revolution of new technology will have to change the way people think about genetic coding, however it is a fundamental step in creating revolutionary innovations to better the future as whole; the biotechnology revolution is far more essential compared to the IT revolution.
The challenges stemming from fundamental research, ethical awareness, policy breakthroughs, and environmental issues will be greater, but the future development of gene technology and artificial intelligence will become the next generation of revolutionary technology to determine the future of humankind.